News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Baxter Jeff
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2023 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Granted 100,000 options to buy
@ $0.575, valued at
$57.5k
|
|
| 01/31/2022 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Granted 800,000 options to buy
@ $1.53, valued at
$1.2M
|
|
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Granted 1,000,000 options to buy
@ $3.15, valued at
$3.2M
|
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Baxter Jeff (Director) has filed a Form 4 on ChromaDex Corp.|
Txns:
| Granted 20,000 options to buy
@ $4.67, valued at
$93.4k
|
|
| 01/24/2020 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Granted 500,000 options to buy
@ $1.46, valued at
$730k
|
|
| 09/30/2019 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Bought 150,000 shares
@ $0.503, valued at
$75.5k
|
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2019 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Bought 144,000 shares
@ $0.7315, valued at
$105.3k
|
|
| 06/18/2019 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Exercised 31,250 options to buy
@ $0 |
|
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/07/2018 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Bought 8,100 shares
@ $1.9268, valued at
$15.6k
|
|
| 08/06/2018 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Bought 13,500 shares
@ $2.0082, valued at
$27.1k
|
|
| 08/01/2018 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Bought 16,800 shares
@ $2.276, valued at
$38.2k
|
|
| 06/26/2018 |
4
| Baxter Jeff (Director) has filed a Form 4 on ChromaDex Corp.|
Txns:
| Granted 20,000 options to buy
@ $3.83, valued at
$76.6k
|
|
| 06/18/2018 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Exercised 31,250 options to buy
@ $0 |
|
| 05/25/2018 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Bought 11,000 shares
@ $2.99, valued at
$32.9k
|
|
| 05/14/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2018 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Granted 150,000 options to buy
@ $4.19, valued at
$628.5k
|
|
| 12/13/2017 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Bought 5,391 shares
@ $3.89, valued at
$21k
Bought 4,609 shares
@ $3.88, valued at
$17.9k
|
|
| 11/29/2017 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI Vaccines Inc/BC|
Txns:
| Bought 15,000 shares
@ $4.75, valued at
$71.3k
|
|
| 08/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/27/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 04/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/19/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|